V0Y

4-[2-(4-aminopiperidin-1-yl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-4-yl]-2-fluorobenzonitrile

Created:	2020-06-11
Last modified:	2020-10-21

Find Related PDB Entry
1 entries where V0Y is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	56
Chiral Atom Count	0
Bond Count	59
Aromatic Bond Count	12

2D diagram of V0Y

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[2-(4-aminopiperidin-1-yl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-4-yl]-2-fluorobenzonitrile
Systematic Name (OpenEye OEToolkits)	4-[2-(4-azanylpiperidin-1-yl)-5-(3-fluoranyl-4-methoxy-phenyl)-1-methyl-6-oxidanylidene-pyrimidin-4-yl]-2-fluoranyl-benzenecarbonitrile
Formula	C₂₄ H₂₃ F₂ N₅ O₂
Molecular Weight	451.469
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	N#Cc1c(cc(cc1)C=3N=C(N2CCC(N)CC2)N(C(C=3c4cc(F)c(OC)cc4)=O)C)F
SMILES	CACTVS	3.385	COc1ccc(cc1F)C2=C(N=C(N(C)C2=O)N3CCC(N)CC3)c4ccc(C#N)c(F)c4
SMILES	OpenEye OEToolkits	2.0.7	CN1C(=O)C(=C(N=C1N2CCC(CC2)N)c3ccc(c(c3)F)C#N)c4ccc(c(c4)F)OC
Canonical SMILES	CACTVS	3.385	COc1ccc(cc1F)C2=C(N=C(N(C)C2=O)N3CCC(N)CC3)c4ccc(C#N)c(F)c4
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1C(=O)C(=C(N=C1N2CCC(CC2)N)c3ccc(c(c3)F)C#N)c4ccc(c(c4)F)OC
InChI	InChI	1.03	InChI=1S/C24H23F2N5O2/c1-30-23(32)21(14-5-6-20(33-2)19(26)11-14)22(15-3-4-16(13-27)18(25)12-15)29-24(30)31-9-7-17(28)8-10-31/h3-6,11-12,17H,7-10,28H2,1-2H3
InChIKey	InChI	1.03	NBAIXBAUHIQQGF-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	118483201

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.